Ohio State, Moffitt Form Cancer Research Collaboration for Big Data | Healthcare Informatics Magazine | Health IT | Information Technology Skip to content Skip to navigation

Ohio State, Moffitt Form Cancer Research Collaboration for Big Data

June 4, 2014
by Rajiv Leventhal
| Reprints

Ohio State University’s James Cancer Hospital and Solove Research Institute, and the Tampa, Fla.-based Moffitt Cancer Center are collaborating to form what is likely the world’s largest cancer research collaboration for big data, the organization’s officials say.

Named the Oncology Research Information Exchange Network (ORIEN), the new partnership will launch with over 100,000 consented patients who have agreed to donate their tissue and clinical data for research to understand cancer at the molecular level. M2Gen, a subsidiary of Moffitt, will serve as ORIEN’s operational and commercial provider for support, bringing expertise in data management and informatics.

ORIEN will  utilize a single protocol, Total Cancer Care, to create a collaborative, “rapid learning” environment that will  aim to share de-identified data to accelerate the development of targeted treatments, allowing researchers and clinicians to more quickly match eligible patients to clinical trials and conduct larger and richer analysis, officials say.

Through data analysis and sharing, ORIEN will provide physicians evidence of the best therapeutic options, including clinical trial treatments, specific to a patient’s biological and epidemiological profile, increasing the likelihood of treatment efficacy, speeding response time, and potentially minimizing side effects while improving outcomes. Patients are followed throughout their lifetime and can play an active role in the study of their cancer and improve care for future generations.

ORIEN’s approach to clinical trial matching also presents a significant opportunity for pharmaceutical companies to modernize trial recruitment and facilitate adaptive clinical trial design. Through M2Gen, industry researchers will be able to match their targeted drugs to participating patients within ORIEN cancer center members based on their molecular profile, promoting greater trial efficiency and flexibility.  Ultimately, researchers will be better equipped to identify potential candidates for their drug trials, leading to better outcomes.  ORIEN also creates the ability to accelerate and improve efficiencies of clinical trials and the drug approval process, including post-market surveillance.

“With ORIEN, we’re amassing a true national cancer database for the first time,” said Michael Caligiuri, M.D., director of The Ohio State University Comprehensive Cancer Center and CEO of the James Cancer Hospital and Solove Research Institute.  “The collaboration across academic centers and with healthcare industry will not only help speed discovery, but will also provide patients with more personalized treatment options and ultimately, lead to better outcomes.”

Read the source article at cancer.osu.edu

Topics

News

NewYork-Presbyterian, Walgreens Partner on Telemedicine Initiative

NewYork-Presbyterian and Walgreens are collaborating to bring expanded access to NewYork-Presbyterian’s healthcare through new telemedicine services, the two organizations announced this week.

ONC Releases Patient Demographic Data Quality Framework

The Office of the National Coordinator for Health IT (ONC) developed a framework to help health systems, large practices, health information exchanges and payers to improve their patient demographic data quality.

AMIA, Pew Urge Congress to Ensure ONC has Funding to Implement Cures Provisions

The Pew Charitable Trusts and the American Medical Informatics Association (AMIA) have sent a letter to congressional appropriators urging them to ensure that ONC has adequate funding to implement certain 21st Century Cures Act provisions.

Former Michigan Governor to Serve as Chair of DRIVE Health

Former Michigan Governor John Engler will serve as chair of the DRIVE Health Initiative, a campaign aimed at accelerating the U.S. health system's transition to value-based care.

NJ Medical Group Launches Statewide HIE, OneHealth New Jersey

The Medical Society of New Jersey (MSNJ) recently launched OneHealth New Jersey, a statewide health information exchange (HIE) that is now live.

Survey: 70% of Providers Using Off-Premises Computing for Some Applications

A survey conducted by KLAS Research found that 70 percent of healthcare organizations have moved at least some applications or IT infrastructure off-premises.